A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Clinical trial NCT05889182 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT05889182

Sponsor

AbbVie

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2023-06-21

Primary completion

2028-03-01

Enrollment

1328

View on ClinicalTrials.gov